Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Ross

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
JHLT Open|March 27, 2025
Corrigendum to "Donor-derived cell-free DNA is a valuable monitoring tool after single lung transplantation: Multicenter analysis" [JHLT Open, 6 (2024) 100155]Ambalavanan Arunachalam, Fatima Anjum, Justin P Rosenheck, et al.
Transplantation|March 13, 2002
Interleukin-1 receptor antagonist as a biomarker for bronchiolitis obliterans syndrome in lung transplant recipientsJohn A Belperio, Bruno DiGiovine, Michael P Keane, et al.
Transplantation|April 29, 2004
Sirolimus-associated pulmonary toxicityPhuong-Thu T Pham, Phuong-Chi T Pham, Gabriel M Danovitch, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 1, 2009
Treprostinil to reverse pulmonary hypertension associated with idiopathic pulmonary fibrosis as a bridge to single-lung transplantationRajeev Saggar, Shelley S Shapiro, David J Ross, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 22, 2003
Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejectionJohn A Belperio, Michael P Keane, Marie D Burdick, et al.
Transplantation|October 27, 2004
Increased bronchoalveolar lavage human beta-defensin type 2 in bronchiolitis obliterans syndrome after lung transplantationDavid J Ross, Alexander M Cole, Dawn Yoshioka, et al.
Respiratory Medicine|July 16, 2008
Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosisSteven D Nathan, Oksana A Shlobin, Scott D Barnett, et al.
Transplant Immunology|June 2, 2025
Early post-lung transplant cell-free DNA levels are associated with baseline lung allograft dysfunctionAndrea Zajacova, Majd Alkhouri, Goncalo Ferrao, et al.
Pulmonary Circulation|December 24, 2015
Proinflammatory high-density lipoprotein results from oxidized lipid mediators in the pathogenesis of both idiopathic and associated types of pulmonary arterial hypertensionDavid J Ross, Greg Hough, Susan Hama, et al.
Transplantation|April 15, 2008
Bronchoalveolar immunologic profile of acute human lung transplant allograft rejectionAric L Gregson, Aki Hoji, Rajan Saggar, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
JHLT Open|March 27, 2025
Corrigendum to "Donor-derived cell-free DNA is a valuable monitoring tool after single lung transplantation: Multicenter analysis" [JHLT Open, 6 (2024) 100155]Ambalavanan Arunachalam, Fatima Anjum, Justin P Rosenheck, et al.
Transplantation|March 13, 2002
Interleukin-1 receptor antagonist as a biomarker for bronchiolitis obliterans syndrome in lung transplant recipientsJohn A Belperio, Bruno DiGiovine, Michael P Keane, et al.
Transplantation|April 29, 2004
Sirolimus-associated pulmonary toxicityPhuong-Thu T Pham, Phuong-Chi T Pham, Gabriel M Danovitch, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 1, 2009
Treprostinil to reverse pulmonary hypertension associated with idiopathic pulmonary fibrosis as a bridge to single-lung transplantationRajeev Saggar, Shelley S Shapiro, David J Ross, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 22, 2003
Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejectionJohn A Belperio, Michael P Keane, Marie D Burdick, et al.
Transplantation|October 27, 2004
Increased bronchoalveolar lavage human beta-defensin type 2 in bronchiolitis obliterans syndrome after lung transplantationDavid J Ross, Alexander M Cole, Dawn Yoshioka, et al.
Respiratory Medicine|July 16, 2008
Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosisSteven D Nathan, Oksana A Shlobin, Scott D Barnett, et al.
Transplant Immunology|June 2, 2025
Early post-lung transplant cell-free DNA levels are associated with baseline lung allograft dysfunctionAndrea Zajacova, Majd Alkhouri, Goncalo Ferrao, et al.
Pulmonary Circulation|December 24, 2015
Proinflammatory high-density lipoprotein results from oxidized lipid mediators in the pathogenesis of both idiopathic and associated types of pulmonary arterial hypertensionDavid J Ross, Greg Hough, Susan Hama, et al.
Transplantation|April 15, 2008
Bronchoalveolar immunologic profile of acute human lung transplant allograft rejectionAric L Gregson, Aki Hoji, Rajan Saggar, et al.
Pageof 7